Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jun;76(3):575-583.
doi: 10.1007/s11418-022-01622-5. Epub 2022 Apr 10.

Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation

Ahmed H H El-Desoky  1   2 , Sachiko Tsukamoto  3
Affiliations
Review

Marine natural products that inhibit osteoclastogenesis and promote osteoblast differentiation

Ahmed H H El-Desoky et al. J Nat Med. 2022 Jun.

Abstract

Osteoporosis is a disease that affects the quality of life of elderly people. The balance between bone formation mediated by osteoblasts and bone resorption by osteoclasts is important to maintain the normal bone condition. Therefore, the promotion of osteoblast differentiation and the suppression of osteoclastogenesis are effective strategies for osteoporosis treatment. Marine organisms are a promising source of biologically active and structurally diverse secondary metabolites, and have been providing drug leads for the treatment of numerous diseases. We describe the marine-derived secondary metabolites that can inhibit receptor activator of nuclear factor-κB ligand (RANKL)-induced osteoclastogenesis and promote osteoblast differentiation.

Keywords: Marine organisms; Osteoblast; Osteoclast; Osteoporosis; RANKL; TRAP.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
RANKL-induced osteoclastogenesis and bone resorption
Fig. 2
Fig. 2
Structures of compounds that inhibited RANKL-induced osteoclastogenesis isolated from cyanobacteria
Fig. 3
Fig. 3
Structures of compounds that inhibited RANKL-induced osteoclastogenesis isolated from a bacterium
Fig. 4
Fig. 4
Structures of compounds that inhibited RANKL-induced osteoclastogenesis isolated from fungi
Fig. 5
Fig. 5
Structures of a compound that inhibited RANKL-induced osteoclastogenesis isolated from a dinoflagellate
Fig. 6
Fig. 6
Structures of compounds that inhibited RANKL-induced osteoclastogenesis isolated from algae
Fig. 7
Fig. 7
Structures of compounds that inhibited RANKL-induced osteoclastogenesis isolated from sponges
Fig. 8
Fig. 8
Structures of compounds that induced osteoblast differentiation
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. Arch Osteoporos. 2013;8(1):136–251. doi: 10.1007/s11657-013-0136-1. - DOI - PMC - PubMed
    1. Wright NC, Looker AC, Saag KG, Curtis JR, Delzell ES, Randall S, Dawson-Hughes B. The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine. J Bone Miner Res. 2014;29(11):2520–2526. doi: 10.1002/jbmr.2269. - DOI - PMC - PubMed
    1. Takusari E, Sakata K, Hashimoto T, Fukushima Y, Nakamura T, Orimo H. Trends in hip fracture incidence in Japan: estimates based on nationwide hip fracture surveys from 1992 to 2017. JBMR Plus. 2021;5(2):e10428. doi: 10.1002/jbm4.10428. - DOI - PMC - PubMed
    1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–1733. doi: 10.1007/s00198-006-0172-4. - DOI - PubMed
    1. Mcgowan JA, Stefanick ML. (2008) Estrogen therapy: prevention and treatment of osteoporosis. In: Marcus R, Feldman D, Nelson D, Rosen C (eds) Osteoporosis, vol I. Academic Press, New York, pp 1687–1703

Substances